MAPT and early-onset autosomal dominant Alzheimer disease: Studies have shown that eight months of treatment of mice with Alzheimer’s disease with donepezil led to improvements in neuroinflammatory changes, tau pathology, synaptic and neuronal loss, and reduced tau protein insolubility and phosphorylation [115,116].